Trisomy 21

One crucial aspect of mitigating the risks associated with pregnancy is ensuring that you are properly screened for potential complications including Down Sydrome (Trisomy 21). As an alternative to invasive screening procedures such as amniocentesis, Eurofins Biomnis offers prenatal Down Syndrome screening kits that deliver fast and accurate results. The NIPT (non-invasive prenatal screening) test draws analysis from a maternal blood sample, and can be undertaken starting at only 10 weeks ofpregnancy. By choosing our non-invasive Trisomy 21 screening test, it can be easily and safely determined whether the risk of fetal defects such as Down Syndrome is high or low, reducing the need for invasive procedures by up to 95%.

Although Down Syndrome gets ample media attention as a common pregnancy risk, expectant parents are often ill-informed about their screening and assessment options, believing that only invasive and potentially risky procedures are available. While amniocentesis tests for Down Syndrome carry some risks, including the potential loss of the fetus, effective non-invasive counterparts are now readily available. By opting for a Eurofins Biomnis NIPT Trisomy 21 test, you can significantly reduce or eliminate the need for invasive prenatal screenings. Safe, reliable, and rapid, the trisomy 21 test can be obtained starting in only the tenth week of pregnancy. They simultaneously detect risks for trisomies 13, 18 and 21.

To detect common fetal chromosomal disorders including Down Syndrome, scheduling a non-invasive Trisomy 21 screening with a primary care physician or other healthcare provider offers patients a safe alternative to invasive methods, as well as considerable peace of mind. In addition to Trisomy 21 screening, Eurofins Biomnis also offers Patau Syndrome diagnosis kits and Edwards' Syndrome (Trisomy 18) tests. These can be ordered to your healthcare provider's office and administered there, or at a Eurofins Biomnis partner laboratory. The procedure is quick and painless, and results are generally available within 7 working days. Moreover, you can take the test from only 10 weeks of amenorrhea, ruling out common prenatal risks early on.